October 17, 2013
Burlingame – Biodesy, Inc., a privately held developer of novel systems to analyze real-time protein function for research and clinical applications, announced today that it has closed a $15.0 million Series A venture financing round from 5AM Ventures, Pfizer Venture Investments and Roche Venture Fund. In addition, Greg Yap has been named Chief Executive Officer [...]
Malvern Instruments launches new models of the Kinexus rotational rheometer
October 17, 2013
Malvern, UK: Malvern Instruments has introduced two new models to its Kinexus line of rotational rheometers. The new Kinexus pro+ and Kinexus ultra+ incorporate enhancements to Malvern’s unique proprietary air bearing technology, the performance defining technology that sits at the heart of the rotational rheometer. These enhancements add to the capabilities of Malvern’s rotational rheometers [...]
SWIFT BIOSCIENCES ANNOUNCES $7 MILLION SERIES B FINANCING
October 17, 2013
Ann Arbor, MI –– Swift Biosciences, Inc., a Michigan-based life sciences company, today announced the recent completion of a $7 million Series B financing led by Fletcher Spaght Ventures. Also joining in the B round of investment was Renaissance Venture Capital Fund and the Series A investors, including the Mercury Fund, Michigan Accelerator Fund and [...]
Boehringer Ingelheim Selects Certara’s D360 as its Global Drug Discovery Platform
October 17, 2013
ST. LOUIS, MO –– Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that the pharmaceutical company Boehringer Ingelheim has chosen D360 as its global drug discovery platform. Certara’s D360 is an integrated solution for the query, analysis and visualization of [...]
NEW Innovative Touch Screen Peristaltic Pump
October 17, 2013
Holliston, MA – KD Scientific, an industry leader in providing liquid handling solutions for industry and bioresearch, today introduced its new Allegro Peristaltic Pump System. This innovative new pumping system allows maintenance free, continuous flow pumping for various fluids. The Allegro™ Peristaltic Pump System can easily dispense in forward or reverse direction using the touch [...]
Biocartis and Hospital del Mar join forces to develop diagnostic colon cancer test
October 17, 2013
Lausanne (Switzerland), Mechelen (Belgium) and Barcelona (Spain) -- Today Biocartis and Hospital del Mar announced their licence agreement on the EGFR biomarker for colon cancer. This agreement enables Biocartis to develop a new colon cancer test, whereby a specific EGFR mutation can be rapidly and accurately detected in patients, which will enable doctors to recommend [...]
Corning Announces New High-Performance Cells for Pharmaceutical Drug Discovery Research
October 17, 2013
CORNING, N.Y. – Corning Incorporated (NYSE: GLW) announces its new Corning® TransportoCells™ designed to help accelerate a key step in the drug discovery and development process. Corning TransportoCells allow researchers to more efficiently screen potential drug candidates for drug-transporter inhibition and drug-transporter-reaction phenotyping, two important parameters related to drug-drug interactions. Corning TransportoCells are high-performance mammalian [...]
October 16, 2013
Spectrographic specialises in metallographic products and equipment for material science analysis and was responsible for installing the new Mitutoyo hardness tester at Sheffield Hallam University as well as training the Thin Films Research team in its use. The Thin Films Centre is dedicated to the study and use of functional coatings for various applications such [...]
Agilent Technologies and Seoul National University Hospital Collaborate on Biomarker Research
October 16, 2013
SANTA CLARA, Calif., and SEOUL, Korea -- Agilent Technologies Inc. (NYSE: A) and Seoul National University Hospital, one of Korea's top medical centers, today announced a strategic collaboration for the development and verification of various biomarkers for the development of drugs, including narcotics, immune-suppressants and biomarkers. "There are gaps in the medical industry that hamper [...]
Harvard Bioscience Names Robert E. Gagnon as Chief Financial Officer
October 16, 2013
HOLLISTON, Mass. -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has hired Robert E. Gagnon, a veteran financial executive, as Harvard Bioscience's Chief Financial Officer, effective as of the date of HBIO's planned spin-off of Harvard Apparatus Regenerative [...]

